BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37237279)

  • 1. ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway.
    Yang H; Huebner K; Hampel C; Erlenbach-Wuensch K; Selvamani SB; Shukla V; Geppert CI; Hartmann A; Mahadevan V; Schneider-Stock R
    BMC Cancer; 2023 May; 23(1):480. PubMed ID: 37237279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
    Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
    J Virol; 2019 May; 93(9):. PubMed ID: 30787154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response.
    Mihanfar A; Asghari F; Majidinia M
    Mol Biol Rep; 2024 Mar; 51(1):474. PubMed ID: 38553623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
    Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
    Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication.
    Edwards TG; Bloom DC; Fisher C
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction.
    Xiao G; Kue P; Bhosle R; Bargonetti J
    Cell Cycle; 2015; 14(5):744-54. PubMed ID: 25565400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation.
    Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM
    Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
    Massey AJ
    Cancer Lett; 2016 Dec; 383(1):41-52. PubMed ID: 27693461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulated Microgravity Promotes Cell Apoptosis Through Suppressing Uev1A/TICAM/TRAF/NF-κB-Regulated Anti-Apoptosis and p53/PCNA- and ATM/ATR-Chk1/2-Controlled DNA-Damage Response Pathways.
    Zhao T; Tang X; Umeshappa CS; Ma H; Gao H; Deng Y; Freywald A; Xiang J
    J Cell Biochem; 2016 Sep; 117(9):2138-48. PubMed ID: 26887372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chk1 and DNA-PK mediate TPEN-induced DNA damage in a ROS dependent manner in human colon cancer cells.
    Rahal ON; Fatfat M; Hankache C; Osman B; Khalife H; Machaca K; Muhtasib HG
    Cancer Biol Ther; 2016 Nov; 17(11):1139-1148. PubMed ID: 27690730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
    Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APE1 assembles biomolecular condensates to promote the ATR-Chk1 DNA damage response in nucleolus.
    Li J; Zhao H; McMahon A; Yan S
    Nucleic Acids Res; 2022 Oct; 50(18):10503-10525. PubMed ID: 36200829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-driven replication stress in nucleoli of malignant epithelial ovarian cancer.
    Guo C; Guo L; Peng C; Jia Y; Yang Y; Wang X; Zeng M; Wang D; Liu C; Zhao M; Chen J; Tang Z
    Exp Cell Res; 2022 Aug; 417(2):113225. PubMed ID: 35644414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
    Ghelli Luserna Di Rorà A; Ghetti M; Ledda L; Ferrari A; Bocconcelli M; Padella A; Napolitano R; Fontana MC; Liverani C; Imbrogno E; Bochicchio MT; Paganelli M; Robustelli V; Sanogo S; Cerchione C; Fumagalli M; Rondoni M; Imovilli A; Musuraca G; Martinelli G; Simonetti G
    Cell Biol Toxicol; 2023 Jun; 39(3):795-811. PubMed ID: 34519926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N; Huang S; Mi QS; Daniel R; Dong Z
    J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct regulation of Chk1 protein stability by E3 ubiquitin ligase HUWE1.
    Cassidy KB; Bang S; Kurokawa M; Gerber SA
    FEBS J; 2020 May; 287(10):1985-1999. PubMed ID: 31713291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHK1 regulates NF-κB signaling upon DNA damage in p53- deficient cells and associated tumor-derived microvesicles.
    Carroll BL; Pulkoski-Gross MJ; Hannun YA; Obeid LM
    Oncotarget; 2016 Apr; 7(14):18159-70. PubMed ID: 26921248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
    Liu K; Graves JD; Lin FT; Lin WC
    J Biol Chem; 2021; 296():100382. PubMed ID: 33556369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB.
    Aasland D; Götzinger L; Hauck L; Berte N; Meyer J; Effenberger M; Schneider S; Reuber EE; Roos WP; Tomicic MT; Kaina B; Christmann M
    Cancer Res; 2019 Jan; 79(1):99-113. PubMed ID: 30361254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.